[1]
Evelyn, E., Djohan, P.B. and Herawati, F. 2022. Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review. Journal of Health Sciences. 15, 03 (Nov. 2022), 218–230. DOI:https://doi.org/10.33086/jhs.v15i03.2788.